» Authors » Gopanandan Parthasarathy

Gopanandan Parthasarathy

Explore the profile of Gopanandan Parthasarathy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 608
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Parthasarathy G, Venkatesan N, Sidhu G, Song M, Liao C, Barrow F, et al.
Hepatol Commun . 2025 Feb; 9(2). PMID: 39899672
Background: Immune cell-driven inflammation is a key mediator of metabolic dysfunction-associated steatohepatitis (MASH) progression. We have previously demonstrated that pharmacological sphingosine 1-phosphate (S1P) receptor modulation ameliorates MASH and is associated...
2.
Wu T, Povero D, Parthasarathy G, Idalsoaga F, Arab J, Ilyas S
Hepatology . 2024 Dec; 76(4):901-902. PMID: 39621485
No abstract available.
3.
Parthasarathy G, Malhi H, Bajaj J
Hepatology . 2024 Jun; PMID: 38922826
Myriad associations between the microbiome and various facets of liver physiology and pathology have been described in the literature. Building on descriptive and correlative sequencing studies, metagenomic studies are expanding...
4.
Parthasarathy G, Mauer A, Golla N, Daniel P, Kim L, Sidhu G, et al.
JCI Insight . 2024 Jan; 9(3). PMID: 38175729
Intrahepatic macrophages in nonalcoholic steatohepatitis (NASH) are heterogenous and include proinflammatory recruited monocyte-derived macrophages. The receptor for advanced glycation endproducts (RAGE) is expressed on macrophages and can be activated by...
5.
Parthasarathy G, Hirsova P, Kostallari E, Sidhu G, Ibrahim S, Malhi H
Compr Physiol . 2023 Jun; 13(3):4631-4658. PMID: 37358519
Extracellular vesicles (EVs) are membrane-bound nanoparticles released by cells and are an important means of intercellular communication in physiological and pathological states. We provide an overview of recent advances in...
6.
Parthasarathy G, Malhi H
Methods Mol Biol . 2022 Feb; 2455:243-254. PMID: 35212999
Hepatocyte lipotoxicity is a hallmark of nonalcoholic steatohepatitis (NASH), and lipid induced liver injury occurs, in part, via activation of endoplasmic reticulum (ER) stress. Consequently, the unfolded protein response (UPR)...
7.
Nakao Y, Amrollahi P, Parthasarathy G, Mauer A, Sehrawat T, Vanderboom P, et al.
Nanomedicine . 2021 Jun; 36:102430. PMID: 34174416
There is increasing interest in the development of minimally invasive biomarkers for the diagnosis and prognosis of NAFLD via extracellular vesicles (EV). Plasma EVs were isolated by differential ultracentrifugation and...
8.
Khan M, Luna-Cuadros M, Lau D, Sehrawat T, Sehrawat O, Schwartz R, et al.
Hepatology . 2021 Jun; 73(6):2085-2088. PMID: 34145622
No abstract available.
9.
Kaur S, Trivedi H, Lau D, Bamidele A, Schwartz R, Parthasarathy G, et al.
Hepatology . 2021 Apr; 73(4):1245-1247. PMID: 33851455
No abstract available.
10.
Catala-Senent J, Hidalgo M, Berenguer M, Parthasarathy G, Malhi H, Malmierca-Merlo P, et al.
Biol Sex Differ . 2021 Mar; 12(1):29. PMID: 33766130
Background: Previous studies have described sex-based differences in the epidemiological and clinical patterns of non-alcoholic fatty liver disease (NAFLD); however, we understand relatively little regarding the underlying molecular mechanisms. Herein,...